glp 1 eating disorder GLP-1 receptor agonists: A novel pharmacotherapy for binge (Binge eating and bulimia nervosa)? A systematic review GLP-1 and Eating Disorders: Risks

Last updated: January 20, 2026 Table of contents What is a subcutaneous injection

(2025) 12:e2411172

We will not manufacture an injection dose to fill a gap that the literature has left empty

In addition, pain sensation does not necessarily correlate with identification of lesions

Does this sound familiar to you

Patients enquiring about GLP-1 agonists for alcohol problems should be directed to evidence-based treatments currently available through NHS addiction services, including community alcohol teams, specialist clinics, and psychological interventions such as cognitive behavioural therapy and motivational enhancement therapy